Lv2
148 积分 2022-01-04 加入
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
6个月前
已完结
Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection
6个月前
已关闭
Unveiling Rosmarinic Acid: Understanding Its Broad Spectrum of Bioactivities
6个月前
已完结
A phase Ⅱ clinical study of the efficacy and safety of antaitasvir phosphate combined with yiqibuvir for the treatment of chronic hepatitis C in adults
7个月前
已完结
[A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C]
7个月前
已完结
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
8个月前
已完结
Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
8个月前
已完结
Breakthroughs in hepatitis C research: from discovery to cure
8个月前
已完结
皖公网安备34019202002308
